Review of the Ophthalmology Innovation Cycle – Panel Discussion

Join William J. Link, PhD as he leads a panel discussion on the risks associated with the innovation cycle and the lessons learned. Moderators: William J. Link, PhD Bill was Founder, Chairman and CEO of Chiron Vision, sold in 1997. Bill founded and served as President of American Medical Optics (AMO), sold in 1986. View…

Read More

“The Long and Winding Road”

The March 14th meeting of the FDA’s Ophthalmic Devices Panel Advisory Committee, which was convened by the FDA to consider the pre-market application (PMA) for STAAR Survival’s toric implantable collamer lens (TICL) brought to my mind the Beatles song “The Long and Winding Road” from their 1970 album “Let it Be.” The reason? It has…

Read More

New Injection Technology Sets the Standard for Icon BioSciences

William S. (Sandy) White, President & CEO for Icon BioSciences, discusses the company’s increasing portfolio of products that target most major therapeutic areas of ophthalmology. Stressing the importance of getting the correct drug, in the correct place, with the best clinical approach, Sandy details the progress of their latest products and briefly highlights their newest…

Read More

VC Says There Are Many ‘Unmet Needs’ in Ophthalmology Space

SAN FRANCISCO — The second annual Ophthalmology Innovation Summit (OIS) was held in conjunction with the American Society of Cataract and Refractive Surgeons (ASCRS; Reston, Virginia). International Business Forum (Massapequa, New York) organized the meeting. The purpose of the OIS conference is to support innovation by facilitating deal-flow and business partnerships between CEOs of young…

Read More

OIS Sets Sights on Anterior Segment Innovations

The second annual Ophthalmology Innovation Summit (OIS) at the 2013 ASCRS•ASOA Symposium & Congress combined industry, clinicians, and entrepreneurs to highlight innovations in anterior segment surgery. The half-day session featured talks on the impact of femtosecond lasers and intraoperative aberrometry, as well as micro-invasive glaucoma surgery (MIGS). Co-chairman William J. Link, PhD, Versant Ventures, Menlo…

Read More

All Eyes on Ophthalmic Innovation: An Interview with Bill Link

The ophthalmology drug, device and medical technology sector is poised for continued growth, as innovators and entrepreneurs unblinkingly stare down the ongoing domino effect being caused by an aging population, which begets a proliferation in eye disease incidence, which, in turn, begets an unprecedented patient base that consequently requires the types of novel ophthalmic products…

Read More

Surgical Treatment of Presbyopia – Challenges and Opportunities

Requesting many highly sought after answers to questions surrounding the surgical treatment of Presbyopia, co-moderators Dick Lindstrom, Founder and Attending Surgeon for Minnesota Eye Consultants and Eugene de Juan, Jr., MD, Founder & Vice-Chairman for ForSight Labs, dig into the underlying challenges and emerging possibilities in Presbyopia surgery. Lending their expertise to provide attendees with…

Read More

Refractive Cataract Surgery – Challenges & Opportunities

Jack Holladay, Clinical Professor of Ophthalmology for Baylor College of Medicine and Jim Mazzo, Retired President for Abbott Medical Optics and Executive Chair for Acufocus, lead a panel discussion on Refractive Cataract Surgery at the 2nd Annual Ophthalmology Innovation Summit on April 18, 2013. Lending expert insights into the current challenges and arising opportunities in…

Read More